問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
CHANGHUA CHRISTIAN HOSPITAL
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2020-06-30 - 2024-10-11
Condition/Disease
To verify the efficacy of Toripalimab combined with Bevacizumab as the firstline therapy for advanced hepatocellular carcinoma (HCC).
Test Drug
Toripalimab (JS001)
Participate Sites3Sites
Recruiting3Sites
2017-02-01 - 2019-04-30
High-Risk Type 2 Diabetes Mellitus (T2DM) Subjects With Coronary Artery Disease (CAD)
RVX000222
Participate Sites14Sites
Terminated14Sites
Division of Cardiovascular Diseases
2007-10-01 - 2010-05-31
Participate Sites2Sites
Terminated2Sites
2007-11-15 - 2008-06-30
Participate Sites24Sites
Terminated23Sites
Study ended1Sites
2007-02-01 - 2008-07-31
Participate Sites4Sites
Study ended4Sites
2007-12-01 - 2009-06-30
Participate Sites6Sites
Terminated6Sites
2008-01-31 - 2009-02-28
Terminated3Sites
2008-03-01 - 2009-03-31
Terminated4Sites
2007-03-01 - 2009-02-28
2010-06-01 - 2011-12-31
Terminated1Sites
Study ended13Sites
全部
